131 related articles for article (PubMed ID: 11282898)
1. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis.
Yamasaki Y; Miyoshi K; Oda N; Watanabe M; Miyake H; Chan J; Wang X; Sun L; Tang C; McMahon G; Lipson KE
Circ Res; 2001 Mar; 88(6):630-6. PubMed ID: 11282898
[TBL] [Abstract][Full Text] [Related]
2. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
[TBL] [Abstract][Full Text] [Related]
3. Tas-301, a new synthetic inhibitor of neointimal thickening after balloon injury, inhibits calcium-dependent signal transduction and cytoskeletal reorganization.
Sasaki E; Miyoshi K; Nozawa Y; Kanda A; Nakano K; Yamasaki Y; Miyake H; Matsuura N
Pharmacology; 2001 Jul; 63(1):17-27. PubMed ID: 11408828
[TBL] [Abstract][Full Text] [Related]
4. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
5. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries.
Muranaka Y; Yamasaki Y; Nozawa Y; Terakawa H; Tanahashi Y; Oda N; Satoh A; Asao T; Miyake H; Matsuura N
J Pharmacol Exp Ther; 1998 Jun; 285(3):1280-6. PubMed ID: 9618434
[TBL] [Abstract][Full Text] [Related]
6. Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells.
Li M; Ping G; Plathow C; Trinh T; Lipson KE; Hauser K; Krempien R; Debus J; Abdollahi A; Huber PE
BMC Cancer; 2006 Mar; 6():79. PubMed ID: 16556328
[TBL] [Abstract][Full Text] [Related]
7. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.
Huang C; Mei H; Zhou M; Zheng X
Mol Med Rep; 2017 Jan; 15(1):21-28. PubMed ID: 27922693
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide.
Mullins DE; Hamud F; Reim R; Davis HR
Arterioscler Thromb; 1994 Jul; 14(7):1047-55. PubMed ID: 8018659
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation.
Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation.
Myllärniemi M; Calderon L; Lemström K; Buchdunger E; Häyry P
FASEB J; 1997 Nov; 11(13):1119-26. PubMed ID: 9367346
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
Wong J; Rauhöft C; Dilley RJ; Agrotis A; Jennings GL; Bobik A
Circulation; 1997 Sep; 96(5):1631-40. PubMed ID: 9315558
[TBL] [Abstract][Full Text] [Related]
12. Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits.
Leppänen O; Rutanen J; Hiltunen MO; Rissanen TT; Turunen MP; Sjöblom T; Brüggen J; Bäckström G; Carlsson M; Buchdunger E; Bergqvist D; Alitalo K; Heldin CH; Ostman A; Ylä-Herttuala S
Circulation; 2004 Mar; 109(9):1140-6. PubMed ID: 14769706
[TBL] [Abstract][Full Text] [Related]
13. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
[TBL] [Abstract][Full Text] [Related]
14. Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery.
Ishii S; Okamoto Y; Katsumata H; Egawa S; Yamanaka D; Fukushima M; Minami S
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):359-66. PubMed ID: 23324994
[TBL] [Abstract][Full Text] [Related]
15. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.
Abe J; Deguchi J; Matsumoto T; Takuwa N; Noda M; Ohno M; Makuuchi M; Kurokawa K; Takuwa Y
Circulation; 1997 Sep; 96(6):1906-13. PubMed ID: 9323080
[TBL] [Abstract][Full Text] [Related]
16. Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo.
Myllärniemi M; Frösen J; Calderón Ramirez LG; Buchdunger E; Lemström K; Häyry P
Cardiovasc Drugs Ther; 1999 Apr; 13(2):159-68. PubMed ID: 10372232
[TBL] [Abstract][Full Text] [Related]
17. Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury.
Kotani M; Fukuda N; Ando H; Hu WY; Kunimoto S; Saito S; Kanmatsuse K
Cardiovasc Res; 2003 Jan; 57(1):265-76. PubMed ID: 12504837
[TBL] [Abstract][Full Text] [Related]
18. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
[TBL] [Abstract][Full Text] [Related]
19. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty.
Nili N; Cheema AN; Giordano FJ; Barolet AW; Babaei S; Hickey R; Eskandarian MR; Smeets M; Butany J; Pasterkamp G; Strauss BH
Am J Pathol; 2003 Sep; 163(3):869-78. PubMed ID: 12937128
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
